Anti-Maxi Potassium channel alpha antibody [L6/60] (ab192759)

Overview

  • Product name
    Anti-Maxi Potassium channel alpha antibody [L6/60]
    See all Maxi Potassium channel alpha primary antibodies
  • Description
    Mouse monoclonal [L6/60] to Maxi Potassium channel alpha
  • Host species
    Mouse
  • Tested applications
    Suitable for: IHC-P, WBmore details
  • Species reactivity
    Reacts with: Mouse, Rat
  • Immunogen

    Fusion protein corresponding to Mouse Maxi Potassium channel alpha (C terminal).

  • Positive control
    • Mouse and Rat Brain This antibody gave a positive result in IHC in the following FFPE tissue: Rat Normal Brain.
  • General notes

    This antibody clone is manufactured by Abcam.

    If you require this antibody in a particular buffer formulation or a particular conjugate for your experiments, please contact orders@abcam.com or you can find further information here.

Properties

Applications

Our Abpromise guarantee covers the use of ab192759 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use a concentration of 5 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
WB Use a concentration of 1 - 5 µg/ml. Detects a band of approximately 105 kDa (predicted molecular weight: 137 kDa).

Target

  • Function
    Potassium channel activated by both membrane depolarization or increase in cytosolic Ca(2+) that mediates export of K(+). It is also activated by the concentration of cytosolic Mg(2+). Its activation dampens the excitatory events that elevate the cytosolic Ca(2+) concentration and/or depolarize the cell membrane. It therefore contributes to repolarization of the membrane potential. Plays a key role in controlling excitability in a number of systems, such as regulation of the contraction of smooth muscle, the tuning of hair cells in the cochlea, regulation of transmitter release, and innate immunity. In smooth muscles, its activation by high level of Ca(2+), caused by ryanodine receptors in the sarcoplasmic reticulum, regulates the membrane potential. In cochlea cells, its number and kinetic properties partly determine the characteristic frequency of each hair cell and thereby helps to establish a tonotopic map. Kinetics of KCNMA1 channels are determined by alternative splicing, phosphorylation status and its combination with modulating beta subunits. Highly sensitive to both iberiotoxin (IbTx) and charybdotoxin (CTX).
  • Tissue specificity
    Widely expressed. Except in myocytes, it is almost ubiquitously expressed.
  • Involvement in disease
    Generalized epilepsy and paroxysmal dyskinesia
  • Sequence similarities
    Belongs to the potassium channel family. Calcium-activated (TC 1.A.1.3) subfamily. KCa1.1/KCNMA1 sub-subfamily.
    Contains 1 RCK N-terminal domain.
  • Domain
    The S0 segment is essential for the modulation by the accessory beta subunits KCNMB1, KCNMB2, KCNMB3 and KCNMB4.
    The S4 segment, which is characterized by a series of positively charged amino acids at every third position, is part of the voltage-sensor.
    The pore-forming domain (also referred as P region) is imbedded into the membrane, and forms the selectivity filter of the pore. It contains the signature sequence of potassium channels that displays selectivity to potassium.
    The RCK N-terminal domain mediates the homotetramerization, thereby promoting the assembly of monomers into functional potassium channel. It includes binding sites for Ca(2+) and Mg(2+).
    The calcium bowl constitutes one of the Ca(2+) sensors and probably acts as a Ca(2+)-binding site. There are however other Ca(2+) sensors regions required for activation of the channel.
    The heme-binding motif mediates inhibition of channel activation by heme. Carbon monoxide-bound heme leads to increased channel activation.
  • Post-translational
    modifications
    Phosphorylated (Probable). Phosphorylation by kinases such as PKA and/or PKG. In smooth muscles, phosphorylation affects its activity.
    Palmitoylation by ZDHHC22 and ZDHHC23 within the intracellular linker between the S0 and S1 transmembrane domains regulates localization to the plasma membrane. Depalmitoylated by LYPLA1 and LYPLAL1, leading to retard exit from the trans-Golgi network.
  • Cellular localization
    Cell membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • subfamily M subunit alpha-1 antibody
    • BK channel antibody
    • BKCA alpha antibody
    • BKCA alpha subunit antibody
    • BKTM antibody
    • Calcium-activated potassium channel antibody
    • Calcium-activated potassium channel subunit alpha-1 antibody
    • Drosophila slowpoke like antibody
    • hSlo antibody
    • K(VCA)alpha antibody
    • KCa1.1 antibody
    • KCMA1_HUMAN antibody
    • KCNMA antibody
    • KCNMA1 antibody
    • Maxi K channel antibody
    • Maxi Potassium channel alpha antibody
    • MaxiK antibody
    • SAKCA antibody
    • SLO alpha antibody
    • SLO antibody
    • Slo homolog antibody
    • Slo-alpha antibody
    • Slo1 antibody
    • Slowpoke homolog antibody
    see all

Images

  • All lanes : Anti-Maxi Potassium channel alpha antibody [L6/60] (ab192759) at 5 µg/ml

    Lane 1 : Human brain tissue lysate - total protein (ab29466)
    Lane 2 : Mouse brain tissue lysate
    Lane 3 : Rat brain tissue lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat Anti-Mouse IgG H&L (HRP) preadsorbed (ab97040) at 1/50000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 137 kDa
    Additional bands at: 110 kDa, 28 kDa (possible non-specific binding). We are unsure as to the identity of these extra bands.


    Exposure time: 20 minutes
  • IHC image of Maxi Potassium channel alpha antibody [L6/60] staining in rat normal brain formalin fixed paraffin embedded tissue section, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab192759, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

    For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

References

ab192759 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab192759.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up